KRTAP20-1
gene geneOn this page
Also known as KAP20.1
Summary
KRTAP20-1 (keratin associated protein 20-1, HGNC:18943) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 20-1 (Q3LI63). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337975 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 8 total
- MANE Select transcript:
NM_181615
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18943 |
| Approved symbol | KRTAP20-1 |
| Name | keratin associated protein 20-1 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP20.1 |
| Ensembl gene | ENSG00000244624 |
| Ensembl biotype | protein_coding |
| Entrez | 337975 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334664
RefSeq mRNA: 1 — MANE Select: NM_181615
NM_181615
CCDS: CCDS13603
Canonical transcript exons
ENST00000334664 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337800 | 30616425 | 30616699 |
Expression profiles
Bgee: expression breadth broad, 28 present calls, max score 38.07.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 38.07 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 28.10 | silver quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| monocyte | CL:0000576 | 27.82 | gold quality |
| leukocyte | CL:0000738 | 27.80 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.26 | silver quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| fundus of stomach | UBERON:0001160 | 24.49 | gold quality |
| skin of abdomen | UBERON:0001416 | 24.25 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| frontal cortex | UBERON:0001870 | 23.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 20-1 — Q3LI63 (reviewed: Q3LI63)
All UniProt accessions (1): Q3LI63
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 20 family.
RefSeq proteins (1): NP_853646* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
| IPR052878 | KRTAP_matrix | Family |
Pfam: PF11759
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI63-F1 | 47.05 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 12 (showing top):
MARTINEZ_RB1_TARGETS_DN, WTGAAAT_UNKNOWN, chr21q22, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MARTINEZ_RB1_AND_TP53_TARGETS_DN, MARTINEZ_TP53_TARGETS_DN, GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
128 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP20-1 | KRTAP15-1 | Q3LI76 | 883 |
| KRTAP20-1 | KRTAP22-1 | Q3MIV0 | 881 |
| KRTAP20-1 | SCYGR1 | A0A286YEY9 | 874 |
| KRTAP20-1 | KRTAP24-1 | Q3LI83 | 871 |
| KRTAP20-1 | KRTAP6-3 | Q3LI67 | 870 |
| KRTAP20-1 | KRTAP26-1 | Q6PEX3 | 812 |
| KRTAP20-1 | KRTAP13-3 | Q3SY46 | 795 |
| KRTAP20-1 | KRTAP6-1 | Q3LI64 | 791 |
| KRTAP20-1 | KRTAP7-1 | Q8IUC3 | 780 |
| KRTAP20-1 | KRTAP27-1 | Q3LI81 | 771 |
| KRTAP20-1 | KRTAP6-2 | Q3LI66 | 764 |
| KRTAP20-1 | KRTAP8-1 | Q8IUC2 | 761 |
| KRTAP20-1 | KRTAP13-1 | Q8IUC0 | 748 |
| KRTAP20-1 | KRTAP11-1 | Q8IUC1 | 711 |
| KRTAP20-1 | KRTAP21-1 | Q3LI58 | 667 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI61, Q3LI63, Q3LI72, Q3SYF9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
99 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30616483:GCTA:G | donor_gain | 0.7300 |
| 21:30616597:G:GT | donor_gain | 0.6500 |
| 21:30616481:T:TA | donor_gain | 0.6400 |
| 21:30616484:C:G | donor_gain | 0.6400 |
| 21:30616482:G:GA | donor_gain | 0.5800 |
| 21:30616490:G:GG | donor_gain | 0.5700 |
| 21:30616478:T:A | donor_gain | 0.5400 |
| 21:30616480:GTGGC:G | donor_gain | 0.5300 |
| 21:30616483:G:GG | donor_gain | 0.5200 |
| 21:30616488:GG:G | donor_gain | 0.5200 |
| 21:30616489:GG:G | donor_gain | 0.5200 |
| 21:30616610:A:AG | donor_gain | 0.4900 |
| 21:30616601:A:G | donor_gain | 0.4700 |
| 21:30616482:GGCTA:G | donor_gain | 0.4500 |
| 21:30616485:TATGG:T | donor_loss | 0.4500 |
| 21:30616486:ATGG:A | donor_loss | 0.4500 |
| 21:30616487:TGG:T | donor_loss | 0.4500 |
| 21:30616488:GGG:G | donor_loss | 0.4500 |
| 21:30616490:GTAT:G | donor_loss | 0.4500 |
| 21:30616491:T:C | donor_loss | 0.4500 |
| 21:30616492:A:C | donor_loss | 0.4400 |
| 21:30616597:G:T | donor_gain | 0.4400 |
| 21:30616633:TAGAG:T | acceptor_gain | 0.4300 |
| 21:30616592:C:G | donor_gain | 0.4200 |
| 21:30616646:A:G | donor_gain | 0.4100 |
| 21:30616607:GTCA:G | donor_gain | 0.4000 |
| 21:30616608:TCAT:T | donor_gain | 0.4000 |
| 21:30616567:G:GT | donor_gain | 0.3900 |
| 21:30616553:C:G | donor_gain | 0.3800 |
| 21:30616609:C:A | donor_gain | 0.3800 |
AlphaMissense
339 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30616617:T:C | F55L | 0.895 |
| 21:30616619:C:A | F55L | 0.895 |
| 21:30616619:C:G | F55L | 0.895 |
| 21:30616620:T:G | Y56D | 0.574 |
dbSNP variants (sampled 300 via entrez): RS1001092125 (21:30615888 A>T), RS1002741151 (21:30615841 G>A), RS1006093814 (21:30615170 G>A), RS1006454122 (21:30615430 G>A,C), RS1007711429 (21:30617069 C>T), RS1008180217 (21:30616672 C>T), RS1008436894 (21:30615321 G>A), RS1009015718 (21:30615593 C>T), RS1010360156 (21:30616848 G>A), RS1010371440 (21:30616508 T>C), RS1011048021 (21:30614755 A>G), RS1013293883 (21:30614881 T>C), RS1013882259 (21:30616409 T>A,C), RS1014349991 (21:30616098 G>A), RS1015996615 (21:30616720 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| polyhexamethyleneguanidine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.